CLB FY 2010 Earnings Report — Core Laboratories N.V. Revenue & Financial Results | Market Cap Arena

Core Laboratories N.V.CLB

FY 2010 Earnings

Reported February 18, 2011

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2010	Prior Q	FY 2009	QoQ Change	YoY Change
Revenue	$795M	—	$696M	—	14.2%
Op. Income	$227M	—	$187M	—	21.5%
Gross Margin	35.3%	—	34.2%	—	1.2pp
Net Margin	18.2%	—	16.3%	—	1.9pp
EPS (Diluted)	$3.00	—	$2.43	—	23.5%
Free Cash Flow	$178M	—	$164M	—	8.3%

Revenue Flow

Item	Amount
REVENUE	$795M
Cost of Revenue	$514M
GROSS PROFIT	$281M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$33M
Other Expenses	$21M
Operating Expenses	$54M
Cost & Expenses	$568M
OPERATING INCOME	$227M
Interest Income	$249.0K
Interest Expense	$16M
Other Income/Expenses	-$18M
INCOME BEFORE TAX	$209M
Income Tax Expense	$64M
Net Income from Continuing Ops	$145M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$145M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$145M
D&A	$23M
EBIT	$225M
EBITDA	$248M
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$795M
Cost of Revenue	$514M
GROSS PROFIT	$281M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$33M
Other Expenses	$21M
Operating Expenses	$54M
Cost & Expenses	$568M
OPERATING INCOME	$227M
Interest Income	$249.0K
Interest Expense	$16M
Other Income/Expenses	-$18M
INCOME BEFORE TAX	$209M
Income Tax Expense	$64M
Net Income from Continuing Ops	$145M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$145M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$145M
D&A	$23M
EBIT	$225M
EBITDA	$248M
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$145M
Depreciation & Amortization	$23M
Stock-Based Compensation	$9M
Deferred Income Tax	-$10M
Other Non-Cash Items	$17M
Change in Working Capital	$22M
OPERATING CASH FLOW	$206M
Capital Expenditure	-$28M
Acquisitions (Net)	-$9M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$30M
NET CASH FROM INVESTING	-$39M
Net Debt Issuance	-$82M
Common Stock Repurchased	-$92M
Common Dividends Paid	-$40M
Other Financing Activities	-$233.0K
NET CASH FROM FINANCING	-$214M
FREE CASH FLOW	$178M
Net Change in Cash	-$47M

Balance Sheet

Item	Amount
Cash & Equivalents	$134M
Short-Term Investments	$0
Net Receivables	$155M
Inventory	$34M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$349M
PP&E (Net)	$104M
Goodwill	$154M
Intangible Assets	$9M
Long-Term Investments	$0
Tax Assets	$0
Other Non-Current Assets	$20M
TOTAL NON-CURRENT ASSETS	$287M
TOTAL ASSETS	$636M
Account Payables	$45M
Short-Term Debt	$0
Deferred Revenue	$20M
Other Current Liabilities	$168M
TOTAL CURRENT LIABILITIES	$279M
Long-Term Debt	$9M
Deferred Revenue NC	$21M
Deferred Tax Liabilities	$2M
Other Non-Current Liabilities	$32M
TOTAL NON-CURRENT LIABILITIES	$64M
TOTAL LIABILITIES	$344M
Common Stock	$1M
Additional Paid-In Capital	$0
Retained Earnings	$537M
Treasury Stock	-$243M
Accum. Other Comp. Income	-$6M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$289M
Minority Interest	$3M
TOTAL EQUITY	$292M
TOTAL LIABILITIES & EQUITY	$636M
Total Debt	$156M
Net Debt	$23M